Smokable cannabis-based product with reduced psychoactive effects

Abstract

A method of preparing a smokable cannabis -based product with reduced psychoactive effects and method for producing the same, comprising the steps of: (a) separating portions with known low tetrahydrocannabinol content from harvested plant material of the cannabis ; (b) separating plant matter which has previously been used in a cannabis oil extraction process; (c) combining specific amounts of the separated materials to produce a cannabis plant material mixture possessing a specific active cannabis compound profile using a mixing device; and (d) loading the mixture of cannabis plant material into the cylindrical smokable tube using a loading device.

What is claimed is: 
     
         1 . A method of preparing a smokable  cannabis -based product with reduced psychoactive effects and method for producing the same, comprising the steps of:
 (a) separating low-content plant matter from harvested plant material of a  cannabis  plant, the low-content plant matter having known low tetrahydrocannabinol content and at least a portion of the plant material comprising  cannabis  plant fan leaves of the  cannabis  plant;   (b) selecting used plant matter which has previously been used in a  cannabis  oil extraction process;   (c) combining a portion of each of the low-content plant matter and the used plant matter to produce a  cannabis  plant material mixture using a mixing device, the  cannabis  plant material mixture possessing a specific active  cannabis  compound profile, wherein the  cannabis  plant material mixture comprises one or more  cannabis  strains each expressing known concentrations of a plurality of active  cannabis  compounds, the known concentrations being determined using an extract from each  cannabis  strain and expressed as a ratio of weight-of-compound per weight-of-extract; and   (d) loading the  cannabis  plant material mixture into a cylindrical smokable tube using a loading device.   
     
     
         2 . The method of  claim 1 , wherein the  cannabis  compound profile formulation comprises at least 10% by weight of purified Δ-9-tetrahydrocannabinol. 
     
     
         3 . The method of  claim 1 , wherein the  cannabis  compound profile formulation at least 45% by weight of purified cannabidiol. 
     
     
         4 . The method of  claim 1 , wherein the  cannabis  plant material mixture further comprises hemp plant matter. 
     
     
         5 . The method of  claim 1 , wherein the  cannabis  compound profile formulation comprises at least 5% by weight of purified β-myrcene. 
     
     
         6 . The method of  claim 1 , further comprising  cannabis  compounds chosen from a set comprising myrcene, α pinene, ocimene, terpineol, beta-caryophyllene, linalool, limonene, terpinolene, valencene, geraniol, phellandrene, carene, terpinene, fenchol, borneol, bisabolol, phytol, camphene, sabinene, camphor, isoborneol, menthol, cedrene, nerolidol, guaiol, isopulegol, geranyl, cymene, and eucalyptol. 
     
     
         7 . A smokable therapeutic  cannabis -based product produced according to the method of  claim 1 . 
     
     
         8 . A smokable therapeutic  cannabis -based product produced according to the method of  claim 2 . 
     
     
         9 . A smokable therapeutic  cannabis -based product produced according to the method of  claim 3 . 
     
     
         10 . A smokable therapeutic  cannabis -based product produced according to the method of  claim 4 . 
     
     
         11 . A smokable therapeutic  cannabis -based product produced according to the method of  claim 5 . 
     
     
         12 . A smokable therapeutic  cannabis -based product produced according to the method of  claim 6 .